ÐÇ¿ÕÓéÀÖ¹ÙÍø

Skip Navigation LinksSkip Navigation Links

Blue White
bottom curve
spacer spacer
spacer
Blue curve MMWR spacer
spacer
spacer

Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: [email protected]. Type 508 Accommodation and the title of the report in the subject line of e-mail.

Notice to Readers: Guidance for Presentation of Economic Studies to the Advisory Committee on Immunization Practices

The charter of the Advisory Committee on Immunization Practices (ACIP) states that committee deliberations on the appropriate use of vaccines should include consideration of population-based studies such as efficacy, cost-benefit, and risk-benefit analyses (1). As the number and cost of vaccines have increased, economic analyses have become an essential aspect of the development of policy recommendations for their use. To ensure that economic data presented to the ACIP and its working groups are of the highest scientific quality, readily understandable, and uniform in presentation, ÐÇ¿ÕÓéÀÖ¹ÙÍø economists have developed Guidance for Health Economics Studies Presented to the ACIP. This guidance, approved by ACIP on June 27, 2007, mandates formal technical review of any economic study before its presentation to the ACIP, effective as of the ACIP meeting, June 25--26, 2008.

The Guidance requires that all economic data presented to the ACIP be reviewed by anonymous peer reviewers within ÐÇ¿ÕÓéÀÖ¹ÙÍø. When a reviewer with a particular area of economic expertise is not available within ÐÇ¿ÕÓéÀÖ¹ÙÍø, external reviewers may be used. Materials to be submitted for review must include a report that provides the methods and results of the study, slides, and other presentation materials as needed. The report and other materials must be sent to the appropriate ACIP working group no later than 8 weeks before the ACIP general meeting or working group meeting at which the analysis is scheduled to be presented. Reviewers will consult with relevant ÐÇ¿ÕÓéÀÖ¹ÙÍø subject-matter experts and return comments and questions in writing to the National Center for Immunization and Respiratory Diseases lead economist (or designee) at least 4 weeks in advance of the formal presentation. Additional details are included in the guidance document, which is available at .

Reference

  1. ÐÇ¿ÕÓéÀÖ¹ÙÍø. ACIP charter. Atlanta, GA: US Department of Health and Human Services, ÐÇ¿ÕÓéÀÖ¹ÙÍø; 2007. Available at .

Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.


References to non-ÐÇ¿ÕÓéÀÖ¹ÙÍø sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by ÐÇ¿ÕÓéÀÖ¹ÙÍø or the U.S. Department of Health and Human Services. ÐÇ¿ÕÓéÀÖ¹ÙÍø is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.

Disclaimer   All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

**Questions or messages regarding errors in formatting should be addressed to [email protected].

Date last reviewed: 2/6/2008

HOME  |  ABOUT MMWR  |  MMWR SEARCH  |  DOWNLOADS  |  RSSCONTACT
  |    | 

Safer, Healthier People

Morbidity and Mortality Weekly Report
Centers for Disease Control and Prevention
1600 Clifton Rd, MailStop E-90, Atlanta, GA 30333, U.S.A